Dr Christian Bannister
Chief Executive Officer
Christian is an experienced data scientist and project manager with a proven track record of delivering data products on time and within budget. He has a PhD from Cardiff University and is an experienced biostatistician and statistical programmer, specialising in analysis of real-world data for pharmacoepidemiological, health economic and outcomes research. Christian's principal research interests lie in the clinical prediction modelling, machine learning and survival analysis.
He has a broad experience as a biostatistician including epidemiology, risk prediction and outcomes research - working in diverse therapeutic areas, such as cardiology, endocrinology, hepatology, immunology, and neurology. Christian has over 15 years programming and analytical experience, including frequentist statistics, decision analytic modelling, machine learning and high performance computing. He has effectively lead large teams and successfully delivered complex multidisciplinary projects.
Christian has previously been an associate staff member in the MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, a member of the Genetic and Environmental Risk in Alzheimer's Disease (GERAD), International Genomics of Alzheimer's Project (IGAP) and Dementia Platform UK (DPUK) collaborations.
Chief Technical Officer
James graduated with a degree in Computer Science and Modern Languages and has spent the last 15 years delivering software projects of all sizes. His particular expertise is in web technologies, cloud infrastructure and delivering systems with a focus on a high quality user experience.
James has a track record of delivering high quality & intuitive data analysis tools to the healthcare industry over the past 6 years, including extensive work with large real-world healthcare datasets including CPRD, THIN and the SAIL databank.
Dr Chris Poole
Chris originally trained as a clinical pharmacist before graduating from Cardiff University with a PhD in Pharmacoepidemiology and transferring these skills to a research career. He has extensive experience as an analyst of UK anonymised patient-level data from sources such as CPRD and THIN, and has co-authored over one hundred peer-reviewed publications across many clinical disciplines including diabetes, cardiovascular medicine, rheumatology, dermatology and pain medicine.
Additionally, having led numerous reimbursement submissions, Chris has developed extensive knowledge of health technology assessment in particular the evidence synthesis requirements.
Chris has previously held academic research positions at Cardiff University, most recently in the Cochrane Institute of Primary Care and Public Health, School of Medicine at Cardiff University, a member of the MRC-funded CIPHeR collaboration. In 2014/15, Chris worked in the European headquarters of a Top 20 global pharmaceutical company where his work to establish a real-world data analytics infrastructure was recognised with a company digital innovation award.
Customer Relationship Director
After a clinical career in Cardiac nursing in both the UK and USA, Christie has spent the last 15 years in various roles relating to health economics, value communications and market access. These roles have varied from research and writing, to project design and management, business unit directorship and sales. She is essentially a commercially minded Health Outcomes and Outcomes Research expert, with good working knowledge of the challenges and opportunities for market access relating to pharmaceuticals and medical devices.
Christie has designed and project managed numerous Real World Evidence (RWE) studies ensuring the correct balance between academic robustness alongside commercial potential and the ultimate goal of improving patient lives. Christie has also held various University level research and guest lecturing roles in related fields.
About Digital Health Labs
Digital Health Labs is an innovative research consultancy specialising in real-world data analytics, health economics & outcomes research.
We have particular expertise in using advanced analytics and cutting-edge technologies to help our clients gain clarity on the value of their pharmaceutical products and services.
We have an in-depth knowledge of the UK real-world evidence landscape and a proven track record of supporting our clients with health technology assessment submissions to European agencies including NICE, SMC, and AWMSG.
Our agile multidisciplinary approach combines a diverse range of people, data and technologies to deliver research in a robust, reproducible and interactive manner that adds real value for our clients.